H.I.G. HealthBridge Partners — Full Portfolio

RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision.

HardwareHealthtechMedical DevicesPasadena, US

Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRKRon Kurtz(Chief Medical Officer (former President & CEO))MWMark Wilterding(Chief Financial Officer)in

Co-investorsFLFlying L PartnersFOForesite CapitalH.H.I.G. CapitalLOLongitude CapitalRARA CapitalVIVisionary Ventures+2 more

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsANAndera PartnersF-F-Prime CapitalH.H.I.G. CapitalBRBRV Capital ManagementEQEQT Life SciencesH.H.I.G. BioHealth Partners

Augmedics develops augmented reality surgical navigation technology aimed at improving outcomes in spine surgery.

HardwareHealthtechMedical DevicesArlington Heights, US

Nissan Elimelech(Chief Executive Officer)in

Co-investorsALAlmeda VenturesEVEvidity Health CapitalH.H.I.G. CapitalPAPartners ResoluteTETerra Venture PartnersXRXR Invest

BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development.

Advanced ManufacturingBiotechHealthtech

Co-investorsH.H.I.G. Capital

Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients.

BiotechDigital HealthHealthtechMedical DevicesLincoln, US

Co-investorsAEAea InvestorsBABain Capital VenturesH.H.I.G. CapitalSVSV Health InvestorsTHTHL FUND

Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.

BiotechDigital HealthHealthtechMedical DevicesNew York, US

DBDavid B. Klein(Founder and CEO)inRSRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)

BoardAlex Zisson(Director)

Co-investorsACAccelmed PartnersH.H.I.G. CapitalHEHealth Catalyst CapitalHIHikma VenturesRERevelation PartnersSASanofi Ventures+5 more

Highridge Medical presents itself as a medical company built on a history of product innovation, led by an executive leadership team.

HardwareHealthtechMedical Devices

Co-investorsCOCorewell Health VenturesH.H.I.G. Capital

BiotechHealthtechWayne, US

Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)

Co-investors41415 CapitalH.H.I.G. CapitalRURunway Growth CapitalH.H.I.G. BioHealth PartnersNENew Enterprise Associates (NEA)VEVensana Capital

Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.

BiotechHealthtechMedical DevicesDenver, US

Co-investorsCOCorewell Health VenturesDEDementia Discovery FundESEscalate Capital PartnersFRFrazier Healthcare PartnersH.H.I.G. CapitalINIntermountain Health+4 more

Navitas Life Sciences is a global clinical research partner providing clinical, regulatory, safety, and data management solutions to pharmaceutical, biotech, and federal agencies for drug development and patient safety.

BiotechData & InfrastructureDigital HealthHealthtechMedical Devices

Srinivasan H.R.(Chief Executive Officer)

Co-investorsH.H.I.G. Capital

BiotechBridgewater, US

Navneet Puri(Executive Officer)

Co-investorsH.H.I.G. CapitalOXOxford Finance LLC

On Target Laboratories is a company of scientists and researchers focused on cancer surgery, developing products to support surgical oncology.

BiotechHealthtechMedical Devices

BPBill Peters(President, Chief Executive Officer, and Board Member)inRMRod MacLeod(Chief Financial Officer)inTLTommy Lee(Senior Vice President of Clinical Operations)inCBCatherine Brisson(Vice President of Regulatory Affairs and Quality)AFAnne Fornicola(Vice President of Chemistry, Manufacturing and Controls)inSHScott Huennekens(Executive Chairperson)in

Co-investors3B3B Future Health FundCECerity Partners VenturesELElevate VenturesH.H.I.G. CapitalH.H.I.G. BioHealth Partners

Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy.

BiotechHealthtechAptos, US

JLJason Levin(Founder, Director and Chief Executive Officer)Robert M. Myers(Executive Officer, Director)

BoardMichael Wasserman(Director)PEPatrick Enright(Director)inElisha (Terry) Gould(Director)Ernest Mario(Director)

Co-investorsH.H.I.G. CapitalLOLongitude CapitalABAbingworthADAdams Street PartnersAGAgent Capital

Specialty pharmaceutical company built on patent-protected dermal delivery technologies.

Co-investorsH.H.I.G. Capital

Develops and markets generic and specialty branded pharmaceutical products, based in New Brunswick, NJ.

Co-investorsH.H.I.G. Capital

Taconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services.

BiotechDeep TechHealthtech

Co-investorsAVAvistaH.H.I.G. Capital

Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions.

Digital HealthHealthtechMedical Devices

Co-investors7W7wire VenturesCOCorewell Health VenturesGEGeneral CatalystH.H.I.G. CapitalSVSV Health InvestorsACAccel+3 more